FindTrial
Sign In

The study of Emodin effects in peripheral blood neutrophil apoptosis in patients with acute pancreatitis

The study of Emodin effects in peripheral blood neutrophil apoptosis in patients with acute pancreatitis

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14004653
Enrollment
Unknown
Registered
2014-05-06
Start date
2014-06-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute pancreatitis

Interventions

dexamethasone:dexamethasone
Emodin in combination with dexamethasone:Emodin in combination with dexamethasone
Emodin:Emodin
Healthy control:Healthy control
acute pancreatitis:Healthy control

Sponsors

Department of General Surgery, First Affiliated Hospital, Dalian Medical University, Dalian, Liaoning 116011, P.R. China
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Adult patients 18 yr-80 yr;Complying with the diagnostic standard of acute pancretitis (clinical symptoms and signs, elevated blood and urine amylase, or imaging criteria).

Exclusion criteria

Exclusion criteria: Pregnancy; Nursing mother; Critical cases of advanced tumor; On the verge of death (estimated to be moral in 12h).

Design outcomes

Primary

MeasureTime frame
blood amylase;Abdominal computerized tomography;Ranson scor;—

Secondary

MeasureTime frame
blood cell analysis;Electrolyte analysi;—

Contacts

Public ContactShang Dong
tougao1971@163.com+86 13500743383

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026